Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Mqv
Very Weak
Garp
Very Weak
Mqv Small
Neutral
Value
Consensus
Price
Weak
Earnings
Very Weak
Earnings
Very Weak
Dividends
Very Weak
Capital Efficiency
Very Weak
Balance Sheet
Very Weak
Website
Arovella Therapeutics Limited
Telephone
61.3.9824.5254
Address
84 Hotham Street, Corporate One, Preston, Victoria (VIC) 3072
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.06 - 0.12
Trade Value (12mth)
AU$27,925.00
1 week
-5.63%
1 month
-11.84%
YTD
-27.96%
1 year
-11.84%
All time high
14.78
EPS 3 yr Growth
-56.70%
EBITDA Margin
NaN%
Operating Cashflow
-$7m
Free Cash Flow Return
-44.30%
ROIC
-48.00%
Interest Coverage
0.00
Quick Ratio
14.20
Shares Outstanding (Fully Diluted)
1,196m
HALO Sector
Healthcare
Next Company Report Date
02-Sep-26
Next Ex Dividend Date
N/A
Next Dividend Pay Date
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.00
| Date | Announcements |
| 10 June 26 | |
| 09 June 26 | |
| 26 May 26 | |
| 08 May 26 | |
| 07 May 26 |
Historical data
Forecast data
| AUD | 2021 | 2022 | 2023 | 2024 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |||
| Per Share, Growth & Valuations | |||||||||||||
EPS (Basic) | $ |  | | | | -0.01 | -0.01 | -0.01 | | | | ||
EPS (Fully Diluted) | $ | | | | | -0.01 | -0.01 | -0.01 | | | | ||
Growth | % | | | | | 8.9 | 35 | 26.9 | | | | ||
PE | X | | | | | N/A | N/A | N/A | | | | ||
EV/EBITDA | X | | | | | N/A | N/A | N/A | | | | ||
Ex Dividend Date (est.)
DIV Yield
Franking Level
DPSg
Quality Yield
Falling Divs over next 2
Consensus Score
Recommendation
EPS 1 month Change
Quality Yield
Falling Divs over next 2
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Months Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
